Split Rock Partners

Split Rock Partners, LLC is a venture capital firm based in Eden Prairie, Minnesota, established in 2004. The firm focuses on investing in early-stage companies across the healthcare and software sectors, particularly within the Upper Midwest and West Coast regions of the United States. Split Rock Partners specializes in therapeutic medical devices and web-based business services, including marketing automation and enterprise analytics. The firm typically invests in companies with market sizes exceeding $500 million, aiming for those that can achieve over $1 billion in value and $100 million in revenue within five years. Their investment strategies encompass primary investments, direct secondary, and blended structures, with a preference for leading or co-leading initial investments. With a team that brings over 80 years of venture investing experience, Split Rock Partners emphasizes collaboration with entrepreneurs, fostering relationships built on integrity and mutual respect. The firm has raised substantial capital through multiple funds, underscoring its commitment to supporting promising companies in their growth trajectories.

James Simons

Co-Founder and Managing Director

Jim Simons

Co-Founding Managing Director

David (Dave) Stassen

Co-Founder and Managing Director

Allan Will

Co-Founder and Managing Director

103 past transactions

Gravia

Series E in 2022
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

Gravia

Series D in 2021
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

EBR Systems

Venture Round in 2019
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

EBR Systems

Venture Round in 2017
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

TruSignal

Series A in 2017
TruSignal, LLC offers digital marketing services. It provides display, video, and media campaigns on publisher sites, portals, advertisement networks, trading desks, DSPs, advertisement exchanges, and mobile networks. The company is based in St. Cloud, Minnesota. TruSignal, LLC operates as a subsidiary of xTech Holdings, Inc. As of May 22, 2019, TruSignal, Inc. operates as a subsidiary of TransUnion.

Gravia

Series C in 2017
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

Demandbase

Series H in 2017
Demandbase, Inc. is a provider of marketing solutions tailored for business-to-business (B2B) companies globally. The company specializes in account-based marketing (ABM), offering a comprehensive cloud-based platform that integrates advertising, personalization, and analytics to help marketers effectively connect their campaigns to revenue generation. Demandbase's platform enables B2B marketers to manage account-based campaigns, utilize artificial intelligence to identify buyer interests, and automate sales and marketing actions throughout the ABM funnel. Additionally, it provides tools for performance management, web analytics, and consulting services, facilitating a streamlined approach to achieving revenue goals with optimized resource usage. Founded in 2005 and headquartered in San Francisco, Demandbase has established itself as a key player in the B2B marketing technology landscape.

Sparkcentral

Venture Round in 2016
Sparkcentral Inc. is a company that offers an enterprise social media helpdesk platform designed to facilitate high-volume and real-time customer engagement. The Sparkcentral platform allows customer support teams to efficiently manage social inquiries by consolidating messages from various channels into a secure agent console, which automatically assigns requests to available agents. This system enhances workflow through features like automated responses, internal collaboration, and engagement metrics, ultimately improving customer satisfaction. Sparkcentral serves a diverse client base, including major brands such as Delta Air Lines, Netflix, and T-Mobile. The company, founded in 2012 and headquartered in San Francisco, California, has established strategic partnerships with industry leaders such as Genesys and Calabrio to further enhance its service offerings.

Janrain

Series D in 2015
Janrain, Inc. specializes in customer identity and access management (CIAM) solutions, offering the Janrain Identity Cloud, which is designed for real-time identity management, security, and activation for global enterprises. Founded in 2002 and headquartered in Portland, Oregon, Janrain has expanded its presence with additional offices in cities including Redwood City, Austin, London, Paris, Kyiv, Guadalajara, São Paulo, Ningbo, and Bengaluru. The company serves a diverse range of sectors, including consumer brands, financial services, healthcare, and education, among others. Janrain is noted for its pioneering role in developing social login and for being a founding member of the OpenID Foundation, contributing significantly to digital authentication protocols used worldwide. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, Inc.

Code42

Series B in 2015
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for the business and education sectors. The company's flagship product, Code42 CrashPlan, offers continuous backup of distributed end-user data, enabling organizations to maintain visibility and control over their information. Additionally, Code42 provides Internet2 NET+ CrashPlan, a tailored endpoint backup service for U.S. higher education institutions, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained IT and security teams. The SaaS solution Incydr focuses on safeguarding organizations' intellectual property and sensitive information. With a strategic partnership with Exabeam, Code42 has established itself as a trusted provider, serving over 50,000 organizations globally. Founded in 2001 and headquartered in Minneapolis, Minnesota, the company is backed by prominent investors, including Accel Partners and NEA.

Acquia

Series G in 2015
Acquia Inc. is a provider of cloud-based solutions designed to build, deliver, and optimize digital experiences for various sectors, including government, education, consumer brands, and financial services. Founded in 2007 and headquartered in Boston, Massachusetts, Acquia offers a range of products, including Acquia Cloud, a Platform-as-a-Service for managing Drupal websites, and Acquia Lift, which facilitates the creation of brand and campaign sites. Other notable solutions include Acquia Content Hub for content distribution, Acquia Journey for customer journey mapping, and Acquia Digital Asset Manager for centralizing creative assets. The company's platform enables organizations to enhance customer engagement through cross-channel, contextually relevant digital experiences, supporting clients like the BBC, Nasdaq, and Stanford University in accelerating their time to market. Acquia also offers technical support and services, ensuring clients can effectively implement and maintain their digital strategies.

InsideView

Private Equity Round in 2015
InsideView Technologies, Inc., founded in 2005 and headquartered in San Francisco, California, develops customer relationship management (CRM) solutions aimed at enhancing sales, marketing, and account management. The company offers a suite of products that include data management tools such as InsideView Refresh and InsideView Data Integrity, which facilitate data cleansing and customer data management. Additionally, InsideView provides expert services to help clients navigate data complexities and a lightning data application known as InsideView Append. Its Targeting Intelligence platform leverages machine learning and artificial intelligence to enable sales and marketing teams to identify and engage with key targets more effectively, ultimately leading to improved deal closures and customer retention. More than 500,000 professionals across over 20,000 companies utilize InsideView's solutions, which integrate with major CRM platforms including Microsoft, Salesforce, and Oracle. The company also maintains content partnerships with various data providers, enhancing its capabilities in delivering actionable B2B intelligence.

Gravia

Series B in 2015
Gravie, Inc. operates a health insurance platform that facilitates the comparison and purchase of health insurance plans for individuals, families, and employers. Founded in 2013 and headquartered in Minneapolis, Minnesota, the company provides a comprehensive solution for managing health insurance expenses through its mobile application and website. Gravie allows users to shop for insurance options available on government-run exchanges and directly from insurance companies. The platform also offers tools for employers to design custom benefits plans using a defined contribution approach, enabling them to set a fixed budget for employee health benefits. Additionally, Gravie provides year-round support, financial analysis, and services such as Gravie Care, which assists individuals in managing their healthcare expenses effectively.

EBR Systems

Venture Round in 2015
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Sparkcentral

Series B in 2015
Sparkcentral Inc. is a company that offers an enterprise social media helpdesk platform designed to facilitate high-volume and real-time customer engagement. The Sparkcentral platform allows customer support teams to efficiently manage social inquiries by consolidating messages from various channels into a secure agent console, which automatically assigns requests to available agents. This system enhances workflow through features like automated responses, internal collaboration, and engagement metrics, ultimately improving customer satisfaction. Sparkcentral serves a diverse client base, including major brands such as Delta Air Lines, Netflix, and T-Mobile. The company, founded in 2012 and headquartered in San Francisco, California, has established strategic partnerships with industry leaders such as Genesys and Calabrio to further enhance its service offerings.

Histogenics

Post in 2014
Histogenics Corporation, based in Waltham, Massachusetts, specializes in regenerative medicine with a focus on developing therapies for musculoskeletal conditions. Founded in 2000, the company aims to create innovative solutions for cartilage damage and joint function restoration. Its primary product candidate, NeoCart®, is a tissue implant designed to regenerate healthy cartilage and improve orthopedic outcomes, particularly for knee injuries. By integrating expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors, Histogenics seeks to address degenerative diseases and enhance patient recovery through its advanced regenerative medicine platform. In 2019, Histogenics was acquired by Ocugen, Inc. in a reverse merger transaction.

VoloMetrix

Series B in 2014
VoloMetrix, Inc. is a people analytics technology company that specializes in enhancing organizational performance through the analysis of big data. Founded in 2011 and headquartered in Seattle, with an additional office in San Francisco, VoloMetrix provides solutions that analyze anonymized, aggregated data from corporate communication systems. Its offerings include customizable dashboards, social network graphs, and predictive analysis tools, which help organizations improve workforce planning, drive sales, and enhance employee engagement. The company serves a range of industries, including banking, biotech, software, and professional services, primarily focusing on Fortune 500 companies. VoloMetrix's technology provides executives with insights into employee behaviors and relationships, enabling better organizational alignment and productivity. As of September 2015, VoloMetrix operates as a subsidiary of Microsoft Corporation.

Zyga Technology

Series D in 2014
Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive solutions for lumbar spine conditions. The company offers the SImmetry Sacroiliac Joint Fusion System, which addresses various issues such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology combines a skilled team of engineers, marketing professionals, and management with extensive experience in the spine industry. As of December 31, 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.

Ivantis

Series B in 2014
Ivantis Inc. is dedicated to developing innovative treatments for primary open angle glaucoma, a condition affecting over 60 million people globally. The company has created an intracanalicular scaffold or implantable device designed to alleviate high intraocular pressure in patients, offering a less invasive and more effective therapeutic option. Founded in 2007 and based in Irvine, California, Ivantis also provides a Session Persistence Server, which safeguards telnet task workers against data loss due to network issues and ensures terminal emulation users maintain productivity across various devices and operating systems. As Ivantis advances its glaucoma treatment solutions, it aims to expand its focus to other debilitating ophthalmic diseases. The company primarily serves ophthalmology specialists in the United States, providing its solutions for use in clinical trials.

Colorescience

Series B in 2014
Colorescience, Inc. specializes in the production and sale of mineral-based cosmetics and sunscreen products. Founded in 2000 and based in Carlsbad, California, the company offers a range of treatment products aimed at addressing various skin concerns, including pigmentation, redness, dark circles, and signs of aging, as well as catering to different skin types such as sensitive, oily, and dry skin. Its product line includes UV protectors, primers, foundations, and enhancers, all designed with high-quality ingredients and formulations. Colorescience distinguishes itself in the luxury aesthetic makeup market by focusing on efficacy and ease of use. The company distributes its products through a network of licensed physicians, luxury spas, retailers, and online channels, emphasizing its commitment to reducing skin cancer and other skin conditions.

BlackDuck

Series F in 2014
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.

EBR Systems

Venture Round in 2014
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Acquia

Series F in 2014
Acquia Inc. is a provider of cloud-based solutions designed to build, deliver, and optimize digital experiences for various sectors, including government, education, consumer brands, and financial services. Founded in 2007 and headquartered in Boston, Massachusetts, Acquia offers a range of products, including Acquia Cloud, a Platform-as-a-Service for managing Drupal websites, and Acquia Lift, which facilitates the creation of brand and campaign sites. Other notable solutions include Acquia Content Hub for content distribution, Acquia Journey for customer journey mapping, and Acquia Digital Asset Manager for centralizing creative assets. The company's platform enables organizations to enhance customer engagement through cross-channel, contextually relevant digital experiences, supporting clients like the BBC, Nasdaq, and Stanford University in accelerating their time to market. Acquia also offers technical support and services, ensuring clients can effectively implement and maintain their digital strategies.

Nuvaira

Series D in 2014
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Transcend Medical

Series C in 2014
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

Intacct

Series G in 2014
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

Guardian Analytics

Series E in 2013
Guardian Analytics, Inc. is a company specializing in behavior-based fraud prevention solutions aimed at safeguarding online and mobile banking activities. Founded in 2005 and headquartered in Mountain View, California, the company provides a range of services tailored for enterprise banks, community banks, and credit unions. Its offerings include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. Additionally, Guardian Analytics features a managed service called FraudDESK, which minimizes staffing impact while enhancing fraud protection. The company's advanced platform utilizes behavioral analytics and machine learning to detect and prevent fraudulent activities across various banking channels, including digital banking and real-time transactions. Guardian Analytics serves over 400 financial institutions, helping them mitigate fraud risk, enhance customer trust, and improve operational efficiency while addressing compliance requirements.

InsideView

Series D in 2013
InsideView Technologies, Inc., founded in 2005 and headquartered in San Francisco, California, develops customer relationship management (CRM) solutions aimed at enhancing sales, marketing, and account management. The company offers a suite of products that include data management tools such as InsideView Refresh and InsideView Data Integrity, which facilitate data cleansing and customer data management. Additionally, InsideView provides expert services to help clients navigate data complexities and a lightning data application known as InsideView Append. Its Targeting Intelligence platform leverages machine learning and artificial intelligence to enable sales and marketing teams to identify and engage with key targets more effectively, ultimately leading to improved deal closures and customer retention. More than 500,000 professionals across over 20,000 companies utilize InsideView's solutions, which integrate with major CRM platforms including Microsoft, Salesforce, and Oracle. The company also maintains content partnerships with various data providers, enhancing its capabilities in delivering actionable B2B intelligence.

Vormetric

Venture Round in 2013
Vormetric is the leader in Enterprise Encryption and Key Management for corporations. Vormetric is growing 40% yr/yr. Vormetric is the only vendor that allows corporations to encrypt ALL DATABASE (all versions) and ALL files across the Enterprise. Vormetric's provide very tight access controls to ensure only authorized users and applications can have access to the data. Vormetric claims more than 1,100 customers, including 17 companies of the Fortune 25. Vormetric technology has received strong market validation for its innovative approach to data security, including selection by IBM as the only database encryption solution for DB2 and Informix on LinuxTM, Unix® and Windows; selection by Symantec to provide the Symantec Veritas NetBackupTM Media Server Encryption Option; partnership with Oracle to secure the execution environment for Oracle® Database Vault.

Colorescience

Series A in 2013
Colorescience, Inc. specializes in the production and sale of mineral-based cosmetics and sunscreen products. Founded in 2000 and based in Carlsbad, California, the company offers a range of treatment products aimed at addressing various skin concerns, including pigmentation, redness, dark circles, and signs of aging, as well as catering to different skin types such as sensitive, oily, and dry skin. Its product line includes UV protectors, primers, foundations, and enhancers, all designed with high-quality ingredients and formulations. Colorescience distinguishes itself in the luxury aesthetic makeup market by focusing on efficacy and ease of use. The company distributes its products through a network of licensed physicians, luxury spas, retailers, and online channels, emphasizing its commitment to reducing skin cancer and other skin conditions.

Nuvaira

Series C in 2013
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Janrain

Series C in 2013
Janrain, Inc. specializes in customer identity and access management (CIAM) solutions, offering the Janrain Identity Cloud, which is designed for real-time identity management, security, and activation for global enterprises. Founded in 2002 and headquartered in Portland, Oregon, Janrain has expanded its presence with additional offices in cities including Redwood City, Austin, London, Paris, Kyiv, Guadalajara, São Paulo, Ningbo, and Bengaluru. The company serves a diverse range of sectors, including consumer brands, financial services, healthcare, and education, among others. Janrain is noted for its pioneering role in developing social login and for being a founding member of the OpenID Foundation, contributing significantly to digital authentication protocols used worldwide. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, Inc.

Nexxo Financial

Series F in 2013
Nexxo’s Everyday Financial Services Platform (EFS) enables businesses to offer consumers an integrated suite of financial services including check cashing, money transfer, bill pay, money orders, pre-paid card servicing and phone minute top-ups; all delivered in a common, easy-to-use interface via self-service kiosk, teller-assisted desktop, mobile, and web channels.

Intacct

Venture Round in 2012
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

Nuvaira

Series B in 2012
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

ForSight VISION5

Venture Round in 2012
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in developing innovative drug delivery technologies aimed at treating various eye conditions. The company focuses on creating non-invasive products designed to replace traditional eye drops, offering sustained therapy for significant eye diseases such as glaucoma, dry eye, and allergies. Currently, ForSight VISION5 is in its second Phase 2 clinical study for its lead product, the Helios insert, which represents a significant advancement in ocular treatment options.

Histogenics

Series C in 2012
Histogenics Corporation, based in Waltham, Massachusetts, specializes in regenerative medicine with a focus on developing therapies for musculoskeletal conditions. Founded in 2000, the company aims to create innovative solutions for cartilage damage and joint function restoration. Its primary product candidate, NeoCart®, is a tissue implant designed to regenerate healthy cartilage and improve orthopedic outcomes, particularly for knee injuries. By integrating expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors, Histogenics seeks to address degenerative diseases and enhance patient recovery through its advanced regenerative medicine platform. In 2019, Histogenics was acquired by Ocugen, Inc. in a reverse merger transaction.

Zyga Technology

Series C in 2012
Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive solutions for lumbar spine conditions. The company offers the SImmetry Sacroiliac Joint Fusion System, which addresses various issues such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology combines a skilled team of engineers, marketing professionals, and management with extensive experience in the spine industry. As of December 31, 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.

DFine

Venture Round in 2012
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

Cayenne Medical

Venture Round in 2012
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.

BlueKai

Series D in 2012
BlueKai is a leading data management platform that provides an enterprise solution for managing and activating first, second, and third-party data to enhance marketing effectiveness. It offers a comprehensive system designed for marketers and publishers to optimize their cross-channel marketing strategies, enabling them to unlock reach, scale, and efficiency through data utilization. As a pioneer in the data-driven marketing sector, BlueKai features an advanced Data Management Platform and a well-connected Data Exchange. The company serves thousands of clients and is trusted by numerous Fortune 30 brands to activate their data, solidifying its position as a significant player in the marketing technology landscape. In recognition of its innovation and impact, BlueKai has received accolades such as being named to Forbes' "50 Most Promising US Companies" list and Fast Company's "10 Most Innovative Global Companies in Big Data."

Transcend Medical

Series B in 2012
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

Code42

Series A in 2012
Code42 Software, Inc. is an enterprise SaaS provider specializing in cloud endpoint data protection and security solutions for the business and education sectors. The company's flagship product, Code42 CrashPlan, offers continuous backup of distributed end-user data, enabling organizations to maintain visibility and control over their information. Additionally, Code42 provides Internet2 NET+ CrashPlan, a tailored endpoint backup service for U.S. higher education institutions, and Code42 Next-Gen DLP, a data loss protection solution designed for resource-constrained IT and security teams. The SaaS solution Incydr focuses on safeguarding organizations' intellectual property and sensitive information. With a strategic partnership with Exabeam, Code42 has established itself as a trusted provider, serving over 50,000 organizations globally. Founded in 2001 and headquartered in Minneapolis, Minnesota, the company is backed by prominent investors, including Accel Partners and NEA.

DFine

Venture Round in 2011
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

BlackDuck

Series E in 2011
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.

RF Surgical Systems

Venture Round in 2011
RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical sponges. The RF Surgical Detection System is the preferred solution in more than 1,500 operating rooms, trauma and labor and delivery suites nationwide. Since January 2011, more than 70 hospitals and surgical centers have joined the fast-growing list of care providers using RF Surgical Technology. RF Surgical Systems is based in Bellevue, Washington with R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November 2006.

Entellus Medical

Series E in 2011
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Guardian Analytics

Series D in 2011
Guardian Analytics, Inc. is a company specializing in behavior-based fraud prevention solutions aimed at safeguarding online and mobile banking activities. Founded in 2005 and headquartered in Mountain View, California, the company provides a range of services tailored for enterprise banks, community banks, and credit unions. Its offerings include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. Additionally, Guardian Analytics features a managed service called FraudDESK, which minimizes staffing impact while enhancing fraud protection. The company's advanced platform utilizes behavioral analytics and machine learning to detect and prevent fraudulent activities across various banking channels, including digital banking and real-time transactions. Guardian Analytics serves over 400 financial institutions, helping them mitigate fraud risk, enhance customer trust, and improve operational efficiency while addressing compliance requirements.

Transcend Medical

Series B in 2011
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

Intacct

Venture Round in 2011
Sage Intacct, Inc. is a cloud accounting software company that specializes in providing financial management solutions tailored for financial professionals. Its comprehensive platform includes applications for general ledger accounting, accounts payable, order management, accounts receivable, cash management, and financial reporting, among other functionalities. The company also supports a range of services such as contract and subscription billing, inventory management, project accounting, and vendor payment solutions. Sage Intacct serves a diverse clientele across various sectors, including accounting firms, healthcare, nonprofits, and wholesale distribution, primarily in the North American market. Established in 1999 and headquartered in San Jose, California, the company has expanded internationally with locations in India and Romania. Sage Intacct, formerly known as Intacct Corporation, operates as a subsidiary of The Sage Group plc and is recognized as a preferred provider by the AICPA, garnering high customer satisfaction ratings and multiple awards for its leadership and workplace culture.

8thBridge

Series B in 2011
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Sonoma Orthopedics

Series D in 2011
Sonoma Orthopedic Products specializes in the design, development, and delivery of proprietary orthopedic implants aimed at assisting physicians in the treatment of problematic fractures. The company's innovative WaviBody technology platform facilitates quick and minimally invasive surgical solutions, catering to the needs of active patients. By focusing on advanced orthopedic solutions, Sonoma Orthopedic Products aims to enhance patient recovery and overall quality of care.

EBR Systems

Series D in 2011
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

FamilyFinds

Series A in 2010
FamilyFinds is an online daily promotions site exclusively focused on services and experiences for families, allowing customers to save up to 90% on family-friendly activities, restaurants and services. Currently they offer exclusive deals in Los Angeles and Chicago, with support for more cities on the way. By offering daily deals from hidden gems to popular places, FamilyFinds allows consumers to discover new places to visit, ideas for local family adventures and other value-added content that takes them from deal to experience. Through its members-only daily email, the company shares deals on hand-picked local merchants and insider info on unique family experiences in specific, hyper local communities.

Nuvaira

Series A in 2010
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

DFine

Venture Round in 2010
DFINE Inc. develops minimally invasive therapeutic devices that are used to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures. It offers STAR, a tumor ablation system for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body; vertebral augmentation systems for percutaneous delivery of bone cement and the treatment of pathological fractures; and vertebroplasty systems. The company was founded in 2004 and is based in San Jose, California. As of July 6, 2016, DFINE Inc. operates as a subsidiary of Merit Medical Systems, Inc..

8thBridge

Series A in 2010
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Twelve

Series A in 2010
Twelve manufactures medical devices. It was formerly known as Foundry Newco XII, Inc. The company was incorporated in 2009 and is based in Menlo Park, California.

Amcom Software

Private Equity Round in 2010
Amcom Software specializes in providing communication solutions designed for organizations that require efficient and reliable management of critical communications. Their offerings include advanced software for call center communications, emergency management, wireless messaging middleware, and paging infrastructure. These solutions cater to a diverse range of sectors, including healthcare, hospitality, education, business, industrial, and government. Amcom Software’s products enhance productivity and accuracy in mission-critical situations by offering features such as PC-based attendant consoles, call center recording and quality management, call accounting and reporting, and speech recognition. The company’s software is utilized by numerous leading organizations to streamline their communication processes effectively.

EBR Systems

Venture Round in 2009
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Entellus Medical

Series D in 2009
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Caring.com

Series B in 2009
Caring, LLC operates an online platform designed to assist family caregivers who are seeking information and support for aging loved ones. Founded in 2007 and based in San Mateo, California, the company provides a comprehensive Senior Care Directory that includes assisted living facilities, memory care communities, in-home care agencies, independent living communities, nursing homes, and hospice care centers. With nearly 55,000 consumer ratings and reviews, Caring.com aims to empower caregivers by offering valuable resources, including caregiving content, online support groups, and a toll-free referral line. The company addresses the challenges faced by the over 40 million caregivers in the United States, many of whom have little prior experience in caregiving, by helping them make informed decisions while saving time and money. The team at Caring.com consists of seasoned professionals with extensive experience in health and family media, many of whom are also caregivers themselves.

eBureau

Series C in 2009
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.

Xora

Venture Round in 2009
Xora is a prominent provider of mobile business applications, offering a suite of configurable cloud-based apps designed to enhance productivity for mobile businesses and their field employees. These applications transform any mobile device into an effective tool for productivity and data collection, streamlining operations. Xora's management application processes and analyzes data to facilitate informed decision-making that improves field operations. Furthermore, the solutions are compatible with back-office systems and other applications, enabling the automation of business processes and reducing reliance on manual paperwork. Over 16,000 organizations utilize Xora's offerings daily, benefiting from increased efficiency and cost savings.

Nexis Vision

Series B in 2009
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.

Transcend Medical

Series B in 2009
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

Anulex Technologies

Series D in 2009
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).

Atritech

Venture Round in 2009
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.

EBR Systems

Series C in 2008
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Entellus Medical

Series C in 2008
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Nexxo Financial

Series D in 2008
Nexxo’s Everyday Financial Services Platform (EFS) enables businesses to offer consumers an integrated suite of financial services including check cashing, money transfer, bill pay, money orders, pre-paid card servicing and phone minute top-ups; all delivered in a common, easy-to-use interface via self-service kiosk, teller-assisted desktop, mobile, and web channels.

Miramar Labs

Series B in 2008
Miramar Labs, founded in 2006 and based in Sunnyvale, California, specializes in developing medical devices for aesthetic applications. The company's primary product, the miraDry System, offers a non-invasive solution for adults suffering from primary axillary hyperhidrosis, which is excessive sweating in the underarm area. This innovative system employs microwave energy to selectively target and permanently eliminate sweat and odor glands, providing a long-lasting, non-surgical treatment option that enhances the confidence and quality of life for its users. The miraDry System is specifically designed for underarm treatment and is not applicable for hyperhidrosis in other areas of the body, such as the hands and feet.

Cayenne Medical

Series C in 2008
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.

Nexis Vision

Series A in 2008
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.

Kspine

Series A in 2008
Kspine was developing implantable medical devices for the treatment of spine disorders.

Calabrio

Series B in 2007
Calabrio, Inc. is a customer experience intelligence company that specializes in developing and marketing workforce optimization software solutions for call centers. Its flagship product, Calabrio ONE, is an integrated software suite that includes modules for call recording, quality management, workforce management, and analytics, designed to enhance agent performance and customer insights. The company serves a diverse range of industries, including healthcare, telecommunications, retail, and finance, with over 4,000 clients worldwide. In addition to its software offerings, Calabrio provides professional services such as project management, training, and technical support. Founded in 2007 and headquartered in Minneapolis, Minnesota, Calabrio also has locations in Canada, the United Kingdom, Singapore, and Sweden. The company has been recognized as a leader in its field and is affiliated with notable industry programs, positioning it as a key player in optimizing customer experience through innovative technology.

Evalve

Series D in 2007
Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Atritech

Series D in 2007
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.

Caring.com

Series A in 2007
Caring, LLC operates an online platform designed to assist family caregivers who are seeking information and support for aging loved ones. Founded in 2007 and based in San Mateo, California, the company provides a comprehensive Senior Care Directory that includes assisted living facilities, memory care communities, in-home care agencies, independent living communities, nursing homes, and hospice care centers. With nearly 55,000 consumer ratings and reviews, Caring.com aims to empower caregivers by offering valuable resources, including caregiving content, online support groups, and a toll-free referral line. The company addresses the challenges faced by the over 40 million caregivers in the United States, many of whom have little prior experience in caregiving, by helping them make informed decisions while saving time and money. The team at Caring.com consists of seasoned professionals with extensive experience in health and family media, many of whom are also caregivers themselves.

Mirabilis Medical

Series A in 2007
Mirabilis Medical, Inc. is a medical device company based in Bothell, Washington, that specializes in the development and manufacture of ultrasound devices aimed at the non-invasive treatment of uterine fibroids, a common condition affecting women. Established in 2004, the company provides innovative solutions for gynecologists, utilizing high-resolution ultrasound imaging to accurately locate and treat fibroid tissue deep within the body without the need for incisions or punctures. This proprietary technology allows for effective ablation of pathological tissue while minimizing damage to surrounding areas, positioning Mirabilis Medical as a key player in the field of gynecological treatments.

Compete

Series C in 2007
Compete specializes in providing digital intelligence services that assist brands in enhancing their marketing strategies by analyzing online consumer behavior. The company offers a range of services that include consumer behavior data for competitive research, performance benchmarking, identification of effective keywords, and analysis of referral sources. It enables businesses to gain insights into online market shares, discover competitors' traffic sources, and pinpoint opportunities to enhance website engagement and conversion metrics. Additionally, Compete provides tools for measuring referral partners, creating connections between online and offline efforts, and identifying cross-selling and up-selling opportunities. The company also focuses on mobile behavioral intelligence to understand the impact of mobile devices on consumer shopping habits. Through these services, Compete aims to deliver actionable insights and comprehensive reports that support informed decision-making for brands seeking to improve customer loyalty and reduce operational costs.

eBureau

Series B in 2007
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.

CareParent

Series A in 2007
CareParent Inc. provides online services which include elder care information and resources. The company is based in Palo Alto, California.

Entellus Medical

Series B in 2007
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

ForSight Labs

Series A in 2007
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.

Gearworks

Venture Round in 2007
Gearworks specializes in location-based mobile business applications, partnering with wireless carriers to deliver effective solutions for managing mobile resources. The company offers a range of products under the etrace, Field Force Manager, appmosphere, and OnCare brands. In addition to its mobile management software, Gearworks provides services such as phone programming, provisioning, training, customization, and integration. Its clientele includes small to medium-sized businesses and enterprise customers across various sectors, including construction, healthcare, field service, home and store delivery, utilities, and government services.

Cayenne Medical

Series B in 2007
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.

Transcend Medical

Series A in 2006
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.

MyNewPlace

Series B in 2006
MyNewPlace is a prominent apartment listing website in the United States, facilitating connections between landlords and potential tenants. The platform offers a comprehensive search feature for apartments and homes for rent, along with valuable city information and demographic data. Users can access property details, including photos and videos, as well as integrated mapping to enhance their search experience. MyNewPlace is recognized for its user-friendly design and was a pioneer in incorporating social networking features into the rental process. The company also provides resources such as rental living tips through its blog, LocalTalk. Founded in San Francisco's SoMa neighborhood, MyNewPlace is owned by RealPage, headquartered in Carrollton, Texas. In 2009, the company expanded its offerings with a mobile app that includes GPS-based apartment searches and note-taking capabilities for listings.

Anulex Technologies

Series C in 2006
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).

Entellus Medical

Series A in 2006
Entellus Medical, operating as Stryker ENT, specializes in developing and marketing minimally invasive products for the treatment of chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. The company offers a range of innovative solutions, including the XprESS ENT dilation system, which provides versatility in balloon dilation procedures; the custom-fit XprESS LoProfile; and the LATERA absorbable nasal implant, which supports nasal cartilage. Additionally, Entellus Medical provides various surgical instruments and endoscopic imaging solutions designed to enhance treatment outcomes for ear, nose, and throat physicians and their patients. The FinESS Sinus Treatment is a notable product that allows for effective treatment of chronic rhinosinusitis with minimal invasiveness, typically performed under local anesthesia. Founded in 2006 and headquartered in Plymouth, Minnesota, Entellus Medical collaborates with researchers and clinicians to address the specific needs of patients and healthcare providers. The company operates as a subsidiary of Stryker Corporation.

Atritech

Series C in 2006
Atritech, based in Minneapolis, Minnesota, is a private company founded in 2000 that specializes in developing innovative technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, is a minimally invasive system designed to close the left atrial appendage, where harmful blood clots can form. This device serves as a permanent alternative to long-term anticoagulation therapy, offering patients a means to reduce their stroke risk associated with non-valvular atrial fibrillation. The WATCHMAN Device has been clinically tested in a large randomized trial comparing its effectiveness to traditional Warfarin therapy. Initially implanted in Germany in 2002 and in the United States in 2003, the device has received CE Mark approval and is available in several international markets, though it is currently designated for investigational use only in the United States.

eBureau

Series A in 2006
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.

ForSight Labs

Venture Round in 2006
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.

BigFix

Series E in 2005
BigFix, Inc. offers an IT security and operations platform designed for real-time visibility and control of distributed computing environments, including desktops, mobile devices, and servers. The BigFix Platform enables effective management of IT infrastructures by providing tools for endpoint security, policy enforcement, and automated operations tasks. Key features include asset discovery, patch management, remote control, and software distribution services. Additionally, BigFix provides custom management content through its Policy Content Modules and offers various support and professional services. Established in 1997 and based in Emeryville, California, the company serves a diverse client base, including businesses, government agencies, and public sector institutions.

EBR Systems

Series B in 2005
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Vendavo

Series E in 2005
Vendavo is the provider of price management and optimization software for business-to-business companies worldwide. The Vendavo Enterprise Pricing Suite solves pricing problems by giving businesses true enterprise-wide control of their entire pricing process. Vendavo combines pricing science, pricing best practices, and enterprise-class software to drive improvements in average prices at every stage of the pricing process, from segmentation to deal close. Added up, these improvements deliver significant increases in profits from 10% to 30%. Vendavo is the enterprise price management and optimization solution of choice for some of the worlds biggest companies in chemicals, high-tech, industrial manufacturing, consumer products, mill products and distribution. SAP, the worlds leading provider of business software, with more than 33,200 customers in more than 120 countries, sources its price and margin management solution from Vendavo. It is sold by SAP worldwide under the name SAP Price and Margin Management.

Spanlink Communications

Series A in 2005
Spanlink Communications, Inc. provides business communications technology and network integration solutions in the United States and internationally. It offers packaged applications, such as Spanlink Courtesy Callback that improves customer satisfaction and agent utilization rates; Customer Survey Manager, which provides users with a solution for creating, launching, and managing automated customer feedback surveys; Spanlink Top Customer that enables users to give designated customers attention; and SolutionWatch, an enterprise-grade application monitoring and systems reporting tool to provide alerts on flaws in the voice and data network. The company also provides CentralControl, a system management product that provides the multi-tenancy to manage voice network, enables senior level control at the data center, and provides access for routine changes at the edge; and IVR toolkits for unified customer voice portal, unified contact center enterprise, and unified contact center express platforms. In addition, it offers analysis, design, implementation, validation, launch, transition, and support services; consultative and assessment services, such as solution value analysis, voice readiness assessment, recording studio, reporting assessment, simulation testing, and post-deployment assessment services; and planning, migration, and support services. Further, Spanlink Communications provides contact center solutions, such as unified communications, unified customer contact, and network systems solutions; and interactive intelligence solutions, including enterprise IP telephony, contact center, hosted and on-premise contact center, and business process automation solutions. The company integrates unified communications, customer interaction, workforce optimization, and system management products that exploit the benefits of VoIP network infrastructures. Spanlink Communications, Inc. was founded in 1988 and is based in Minneapolis, Minnesota.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.